Franklin Resources’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.5M | Buy |
821,405
+482,149
| +142% | +$20.8M | 0.01% | 737 |
|
|
2025
Q1 | $11.7M | Buy |
339,256
+330,658
| +3,846% | +$11.4M | ﹤0.01% | 1055 |
|
|
2024
Q4 | $236K | Buy |
8,598
+1,698
| +25% | +$46.6K | ﹤0.01% | 2592 |
|
|
2024
Q3 | $178K | Hold |
6,900
| – | – | ﹤0.01% | 2654 |
|
|
2024
Q2 | $175K | Buy |
6,900
+2,351
| +52% | +$59.6K | ﹤0.01% | 2581 |
|
|
2024
Q1 | $141K | Buy |
+4,549
| New | +$141K | ﹤0.01% | 2651 |
|
|
2022
Q1 | – | Sell |
-286,837
| Closed | -$4.78M | – | 2443 |
|
|
2021
Q4 | $4.78M | Buy |
286,837
+1,505
| +0.5% | +$25.1K | ﹤0.01% | 1231 |
|
|
2021
Q3 | $13.4M | Buy |
285,332
+1,842
| +0.6% | +$86.3K | 0.01% | 988 |
|
|
2021
Q2 | $17.3M | Sell |
283,490
-609
| -0.2% | -$37.1K | 0.01% | 893 |
|
|
2021
Q1 | $17.5M | Buy |
284,099
+30
| +0% | +$1.85K | 0.01% | 863 |
|
|
2020
Q4 | $20.2M | Buy |
284,069
+584
| +0.2% | +$41.5K | 0.01% | 811 |
|
|
2020
Q3 | $10.6M | Buy |
283,485
+185
| +0.1% | +$6.94K | 0.01% | 887 |
|
|
2020
Q2 | $8.75M | Hold |
283,300
| – | – | ﹤0.01% | 891 |
|
|
2020
Q1 | $8.22M | Hold |
283,300
| – | – | 0.01% | 835 |
|
|
2019
Q4 | $9.93M | Sell |
283,300
-66,700
| -19% | -$2.34M | 0.01% | 894 |
|
|
2019
Q3 | $7.52M | Hold |
350,000
| – | – | ﹤0.01% | 925 |
|
|
2019
Q2 | $9.44M | Buy |
+350,000
| New | +$9.44M | 0.01% | 900 |
|